NCT01653041View on ClinicalTrials.gov

Certican (Everolimus) for Recipients of Kidney From HLA-identical Living Donors

PHASE4CompletedINTERVENTIONAL

Enrollment

47

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

August 31, 2014

Study Completion Date

April 30, 2015

Conditions

Kidney Transplantation

Interventions

DRUG

Everolimus

Trial Locations (1)

04038-002

Hospital do Rim e Hipertensão, São Paulo

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Novartis

INDUSTRY

lead

Hospital do Rim e Hipertensão

OTHER